Abstract Improved clinical outcomes are reported for patients with advanced pancreatic adenocarcinoma (PDAC) treated with first-line FOLFIRINOX/NALIRIFOX, but elderly patients with comorbidities are more often… […]
Adult Sarcomas with NTRK Fusions: Clinicopathologic and Genomic Heterogeneity
Simple Summary Adult sarcomas harboring NTRK fusions are rare and represent a biologically heterogeneous group with diverse morphologic, genomic, and clinical features. In this retrospective… […]